hydroxyurea
Drug Details
- Generic Name
- hydroxyurea
- Brand Names
- Siklos
- Application Number
- NDA208843
- Sponsor
- Medunik
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- HYDROXYUREA
Indications and Usage
1 INDICATIONS AND USAGE Hydroxyurea capsules are indicated for the treatment of: • Resistant chronic myeloid leukemia. • Locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation. Hydroxyurea capsules are an antimetabolite indicated for the treatment of: Resistant chronic myeloid leukemia. (1) Locally advanced squamous cell carcinomas of the head and neck, (excluding lip) in combination with concurrent chemoradiation. (1)